Solid Biosciences (SLDB) Treasury Shares (2017 - 2026)

Solid Biosciences has disclosed Treasury Shares across 10 years of filings, most recently posting $1.6 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.6 million, down 28.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 28.16% YoY), and the FY2025 annual result was $2.1 million, up 40.12% from the prior year.
• Treasury Shares came in at $1.6 million for Q1 2026 at Solid Biosciences, down from $2.1 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.8 million in Q3 2025 to a low of $512557.0 in Q4 2022.
• The 5-year median for Treasury Shares is $1.5 million (2024), against an average of $1.8 million.
• Across the five-year window, Treasury Shares jumped 1408.41% in 2022 and decreased 28.16% in 2026, its largest moves.
• Solid Biosciences' Treasury Shares stood at $512557.0 in 2022, then soared by 71.14% to $877181.0 in 2023, then jumped by 68.75% to $1.5 million in 2024, then jumped by 40.12% to $2.1 million in 2025, then fell by 25.0% to $1.6 million in 2026.
• The last three Treasury Shares figures came in at $1.6 million (Q1 2026), $2.1 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.